Literature DB >> 4908562

[Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].

E Böhni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4908562

Source DB:  PubMed          Journal:  Chemotherapy        ISSN： 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  11 in total

1.  Technique for determining the bactericidal effect of drug combinations.

Authors:  V Lorian; G Fodor
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

2.  Horse erythrocyte factor enhancing sulphonamide activity. I. Partial purification and data on the mode of action.

Authors:  E T Gláz; T Machay
Journal:  Folia Microbiol (Praha)       Date:  1972       Impact factor: 2.099

Review 3.  Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.

Authors:  H F Vöhringer; K Arastéh
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

4.  [Long-term treatment of chronic bronchitis with the broadspectrum chemotherapeuticum "Bactrim"].

Authors:  I Marcic; W T Ulmer
Journal:  Pneumonologie       Date:  1970

Review 5.  Advances in MRSA drug discovery: where are we and where do we need to be?

Authors:  Michio Kurosu; Shajila Siricilla; Katsuhiko Mitachi
Journal:  Expert Opin Drug Discov       Date:  2013-07-06       Impact factor: 6.098

6.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

7.  Penetration of trimethoprim and sulfamethoxazole into skin blister fluid.

Authors:  A Nowak; M Kadyków; A Klimowicz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Distribution of trimethoprim and sulphamethoxazole in blood during treatment with co-trimoxazole.

Authors:  A Nowak; A Klimowicz; M Kadyków
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.

Authors:  E Singlas; J N Colin; J Rottembourg; J P Meessen; A de Martin; M Legrain; P Simon
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.

Authors:  B Ortengren; L Magni; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.